Hereditary hemochromatosis: An opportunity for gene therapy

Biological Research

Volumn 39, Issue 1, 2006, Pages 113-124

  Ezquer, Fernando ^a   Núñez, Marco Tulio ^a   Rojas, Alejandro ^a   Asenjo, Juan ^a   Israel, Yedy ^a,b  

^a UNIVERSITY OF CHILE   (Chile)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Cirrhosis; DMT1; Gene therapy; Hemochromatosis; HFE; Intestine; Iron

Indexed keywords

ADENOVIRUS VECTOR; ANTISENSE OLIGONUCLEOTIDE; CHITOSAN; FERROPORTIN 1; HEPCIDIN; IRON; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; PLASMID DNA; RIBOZYME; SMALL INTERFERING RNA;

ANEMIA; CELL MEMBRANE TRANSPORT; CONFERENCE PAPER; DNA PACKAGING; DRUG TARGETING; GENE MUTATION; GENE TARGETING; GENE THERAPY; HEMOCHROMATOSIS; HOMEOSTASIS; HUMAN; IMMUNOGENICITY; INTESTINE ABSORPTION; INTESTINE EPITHELIUM CELL; IRON ABSORPTION; IRON TRANSPORT; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SAFETY; VIRAL GENE DELIVERY SYSTEM;

EID: 33745839602     PISSN: 07169760     EISSN: 07176287     Source Type: Journal    
DOI: 10.4067/S0716-97602006000100014     Document Type: Conference Paper

References (83)

1. ADAMS PC, KERTESZ AE, VALBERG LS (1991) Clinical presentation of hemochromatosis: A changing scene. Am J Med 90: 445-449
2. AHMAD KA, AHMANN JR, MIGAS MC, WAHEED A, BRITTON RS, BACON BR, SLY WS, FLEMING RE (2002) Decreased liver hepcidin expression in the Hfe knockout mouse. Blood Cells Mol Dis 29: 361-366
3. AGUIRRE P, MENA N, TAPIA V, ARREDONDO M, NÚÑEZ MT (2005) Iron homeostasis in neuronal cells: A role for IREG1. BMC Neurosci 6: 3 (online).
4. ANDREWS BA, MANOSALVA H, ISRAEL Y, ASENJO JA (2003) Challenges in the production and purification of first and third generation adenovirus vectors for gene therapy. 12th International Conference on Biopartitioning and Purification, Vancouver, British Columbia, Canada
5. ANDREWS NC (1999) Disorders of iron metabolism. N Engi J Med. 341: 1986-1995
6. ARREDONDO M, MUÑOZ P, MURA CV, NÚÑEZ MT (2001) HFE inhibits apical iron uptake by intestinal epithelial (Caco-2) cells. FASEB J 15: 1276-1278
7. ARREDONDO M, MUÑOZ P, MURA CV, NÚÑEZ MT (2003) DMT1, a physiologically relevant apical Cu1+ transporter of intestinal cells. Am J Physiol Cell Physiol 284: C1525-15230
8. BACON BR, POWELL LW, ADAMS PC, KRESINA TF, HOOFNAGLE JH (1999) Molecular medicine and hemochromatosis: At the crossroads. Gastroenterology 116: 193-207
9. BANNON DI, ABOUNADER R, LEES PS, BRESSLER JP (2003) Effect of DMT1 knockdown on iron, cadmium, and lead uptake in Caco-2 cells. Am J Physiol Cell Physiol 284: C44-50
10. BASTIN JM, JONES M, OCALLAGHAN CA, SCHIMANSKI L, MASON DY, TOWNSEND AR (1998) Kupffer cell staining by an HFE-specific monoclonal antibody: Implications for hereditary haemochromatosis. Br J Haematol 103: 931-941
11. BERNS KI, HAUSWIRTH WW (1979) Adeno-associated viruses. Adv Virus Res 25: 407-449
12. BRIDLE KR, FRAZER DM, WILKINS SJ, DIXON JL, PURDIE DM, CRAWFORD DH, SUBRAMANIAM VN, POWELL LW, ANDERSON GJ, RAMM GA (2003) Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet 361: 669-673
13. BRITTENHAM GM, WEISS G, BRISSOT P, LAINE F, GUILLYGOMARCH A, GUYADER D, MOIRAND R, DEUGNIER Y (2000) Clinical consequences of new insights in the pathophysiology of disorders of iron and heme metabolism. Hemotology 2000: 39-50
14. BUNING H, BRAUN-FALCO M, HALLEK M (2004) Progress in the use of adeno-associated viral vectors for gene therapy. Cells Tissues Organs 177: 139-150
15. CAMASCHELLA C, ROETTO A, CALI A, DE GOBBI M, GAROZZO G, CARELLA M, MAJORANO N, TOTARO A, GASPARINI P (2000) The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet 25: 14-15
16. CARTER PJ, SAMULSKI RJ (2000) Adeno-associated viral vectors as gene delivery vehicles. Int J Mol Med 6: 17-27
17. CHEN J, YANG WL, LI G, QIAN J, XUE JL, FU SK, LU DR (2004) Transfection of mEpo gene to intestinal epithelium in vivo mediated by oral delivery of chitosan-DNA nanoparticles. World J Gastroenterol 10(1): 112-116
18. CROYLE MA, STONE M, AMIDON GL, ROESSLER BJ (1998) In vitro and in vivo assessment of adenovirus 41 as a vector for gene delivery to the intestine. Gene Ther 5: 645-654
19. DAVIES PS, ENNS CA (2004) Expression of the hereditary hemochromatosis protein HFE increases ferritin levels by inhibiting iron export in HT29 cells. J Biol Chem 279: 25085-25092
20. DONOVAN A, BROWNLIE A, ZHOU Y, SHEPARD J, PRATT SJ, MOYNIHAN J, PAW BH, DREJER A, BARUT B, ZAPATA A, LAW TC, BRUGNARA C, LUX SE, PINKUS GS, PINKUS JL, KINGSLEY PD, PALIS J, FLEMING MD, ANDREWS NC, ZON LI (2000) Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 403: 776-781
21. DURING MJ, XU R, YOUNG D, KAPLITT MG, SHERWIN RS, LEONE P (1998) Peroral gene therapy of lactose intolerance using an adeno-associated virus vector. Nat Med 4: 1131-1135
22. ELISMA F, JUMARIE C (2001) Evidence for cadmium uptake through Nramp2: Metal speciation studies with Caco-2 cells. Biochem Biophys Res Commun 285: 662-668
23. EZQUE F, NÚxZ M T, ISRAEL Y (2004) Hemochromatosis: Antisense gene against the DMT-1 transporter inhibits iron uptake in human intestinal cells and shows RNAi and antisense effects. Biol Res 37 (Supplement A): R89
24. EZQUER F, NÚÑEZ M T, ISRAEL Y (2005) Antisense gene delivered by an adenoassociated viral vector inhibits iron uptake in human intestinal cells: Potential application in hemochromatosis. Biochem Pharmacol 69: 1559-1566
25. FEDER IN, GNIRKE A, THOMAS W, TSUCHIHASHI Z, RUDDY DA, BASAVA A, DORMISHIAN F, DOMINGO R JR, ELLIS MC, FULLAN A, HINTON LM, JONES NL, KIMMEL BE, KRONMAL GS, LAUER P, LEE VK, LOEB DB, MAPA FA, MCCLELLAND E, MEYER NC, MINTIER GA, MOELLER N, MOORE T, MORIKANG E, WOLFF RK (1996) A novel MHC class I-like gene is mutated in patients with hereditary
26. FEDER JN, TSUCHIHASHI Z, IRRINKI A, LEE VK, MAPA FA, MORIKANG E, PRASS CE, STARNES SM, WOLFF RK, PARKKILA S, SLY WS, SCHATZMAN RC (1997) The hemochromatosis founder mutation in HLA-H disrupts beta2-microglobulin Interaction and cell surface expression. J Biol Chem 272: 14025-14028
27. FEDER JN, PENNY DM, IRRINKI A, LEE VK, LEBRON JA, WATSON N, TSUCHIHASHI Z, SIGAL E, BJORKMAN PJ, SCHATZMAN RC (1998) The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci USA 95: 1472-1477
28. FLEMING MD, TRENOR CC 3rd, SU MA, FOERNZLER D, BEIER DR, DIETRICH WF, ANDREWS NC (1997) Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nature Genetics 16: 383-386
29. FLEMING MD, ROMANO MA, SU MA, GARRICK LM, GARRICK MD, ANDREWS NC (1998) Nramp2 is mutated in the anemic Belgrade (b) rat: Evidence of a role for Nramp2 in endosomal iron transport. Proc Natl Acad Sci USA 95: 1148-1153
30. FLEMING RE, MIGAS MC, HOLDEN CC, WAHEED A, BRITTON RS, TOMATSU S, BACON BR, SLY WS (2000) Transferrin receptor 2: Continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosis. Proc Natl Acad Sci USA 97: 2214-2219
31. FLEMING RE, BRITTON RS, WAHEED A, SLY WS, BACON BR (2004) Pathogenesis of hereditary hemochromatosis. Clin Liver Dis 8: 755-773
32. FORBES JR, GROS P (2003) Iron, manganese, and cobalt transport by Nramp1 (Slc11a1) and Nramp2 (Slc11a2) expressed at the plasma membrane. Blood 102: 1884-1892
33. GALLI A, BERGAMASCHI G, RECALDE H, BIASIOTTO G, SANTAMBROGIO P, BOGGI S, LEVI S, AROSIO P, CAZZOLA M (2004) Ferroportin gene silencing induces iron retention and enhances ferritin synthesis in human macrophages. Br J Haematol 127: 598-603
34. GANZ T (2003) Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 102: 783-788
35. GOCHEE PA, POWELL LW, CULLEN DJ, DU SART D, ROSSI E, OLYNYK JK (2002) population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation. Gastroenterology 122: 646-651
36. GONIN P, GAILLARD C (2004) Gene transfer vector biodistribution: Pivotal safety studies in clinical gene therapy development. Gene Ther. 11(Suppl 1): S98-S108
37. GRIFFITHS WJ, COX TM (2003) Co-localization of the mammalian hemochromatosis gene product (HFE) and a newly identified transferrin receptor (TfR2) in intestinal tissue and cells. J Histochem Cytochem 51: 613-624
38. GROSS CN, IRRINKI A, FEDER JN, ENNS CA (1998) Co-trafficking of HFE, a nonclassical major histocompatibility complex class I protein, with the transferrin receptor implies a role in intracellular iron regulation. J Biol Chem 273: 22068-22074
39. GUNSHIN H, MACKENZIE B, BERGER UV, GUNSHIN Y, ROMERO MF, BORON WF, NISSBERGER S, GOLLAN JL, HEDIGERe MA (1997) Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 388: 482-488
40. HUBERT N, HENTZE MW (2002) Previously uncharacterized isoforms of divalent metal transporter (DMT)-1: Implications for regulation and cellular function. Proc Nat Acad Sci USA 99: 12345-12350
41. KAWABATA H, YANG R, HIRAMA T, VUONG PT, KAWANO S, GOMBART AF, KOEFFLER HP (1999) Molecular cloning of transferrin receptor 2. A new member of the transferrin receptor-like family. J
42. KRAUSE A, NEITZ S, MAGERT HJ, SCHULZ A, FORSSMANN WG, SCHULZ-KNAPPE P, ADERMANN K (2000) LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett 480: 147-150
43. LAFTAH AH, RAMESH B, SIMPSON RJ, SOLANKY N, BAHRAM S, SCHUMANN K, DEBNAM ES, SRAI SK (2004) Effect of hepcidin on intestinal iron absorption in mice. Blood 103: 3940-3944
44. LEVY JE, MONTROSS LK, COHEN DE, FLEMING MD, ANDREWS NC (1999) The C282Y mutation causing hereditary hemochromatosis does not produce a null allele. Blood 94: 9-11
45. LEVY JE, MONTROSS LK, ANDREWS NC (2000) Genes that modify the hemochromatosis phenotype in mice. J Clin Invest 105: 1209-1216
46. LYNCH SR, SKIKNE BS, COOK JD (1989) Food iron absorption in idiopathic hemochromatosis. Blood 74: 2187-2193
47. MANDEL RJ, BURGER C (2004) Clinical trials in neurological disorders using AAV vectors: Promises and challenges. Curr Opin Mol Ther 6: 482-490
48. MANOSALVA H, KARAHANIAN E, ISRAEL Y, ANDREWS BA, ASENJO JA (2002) Challenges in the design and production of first and third generation adenovirus vectors for gene therapy. 8th International Conference on Cell Culture Engineering, Snowmass, Colorado, USA
49. MCKIE AT, MARCIANI P, ROLFS A, BRENNAN K, WEHR K, BARROW D, MIRET S, BOMFORD A, PETERS TJ, FARZANEH F, HEDIGER MA, HENTZE MW, SIMPSON RJ (2000) A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell 5: 299-309
50. MCKIE AT, BARROW D, LATUNDE-DADA GO, ROLF A, SAGER G, MUDALY E, MUDALY M, RICHARDSON C, BARLOW D, BOMFORD A, PETERS TJ, RAJA KB, SHIRALI S, HEDIGER MA, FARZANEH F, SIMPSON RJ (2001) An iron-regulated ferric reductase associated with the absorption of dietary iron. Science 29: 1755-1759
51. MEUNIER V, BOURRIE M, BERGER Y, FABRE G (1995) The human intestinal epithelial cell line Caco-2; pharmacological and pharmacokinetic applications. Cell Biol Toxicol 11: 187-194
52. MONAHAN PE, SAMULSKI RJ (2000) Adeno-associated virus vectors for gene therapy: more pros than cons? Mol Med Today 6: 433-440
53. MONTOSI G, DONOVAN A, TOTARO A, GARUTI C, PIGNATTI E, CASSANELLI S, TRENOR CC, GASPARINI P, ANDREWS NC, PIETRANGELO A (2001) Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest 108: 619-623
54. NADEAU I, SABATIÉ J, KOEHL M, PERRIER M, KAMEN A (2000a) Human 293 cell metabolism in low glutamine-supplied culture: Interpretation of metabolic changes through metabolic flux analysis. Metabolic Engineering 2: 277-292
55. NADEAU I, JACOB D, PERRIER M, KAMEN A (2000b) 293SF Metabolic flux analysis during cell growth and infection with an adenoviral vector. Biotechnology Progress 16: 872-884
56. NADEAU I, GILBERT PA, JACOB D, PERRIER M, KAMEN A (2001) Low-protein medium affects the 293SF central metabolism during growth and infection with adenovirus. Biotechnology and Bioengineering 77: 93-104
57. NEMETH E, TUTTLE MS, POWELSON J, VAUGHN MB, DONOVAN A, WARD DM, GANZ T, KAPLAN J (2004) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306: 2090-2093
58. NICOLÁS G, BENNOUN M, DEVAUX I, BEAUMONT C, GRANDCHAMP B, KAHN A, VAULONT S (2001) Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci USA 98: 8780-8785
59. NICOLÁS G, BENNOUN M, PORTEU A, MATIVET S, BEAUMONT C, GRANDCHAMP B, SIRITO M, SAWADOGO M, KAHN A, VAULONT S (2002) Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci USA 99: 4596-4601
60. NICOLAS G, VIATTE L, LOU DQ, BENNOUN M, BEAUMONT C, KAHN A, ANDREWS NC, VAULONT S (2003) Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis. Nat Genet 34: 97-101
61. NIEDERAU C, FISCHER R, SONNENBERG A, STREMMEL W, TRAMPISCH HJ, STROHMEYER G (1985) Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med 313: 1256-1262
62. NJAJOU OT, VAESSEN N, JOOSSE M, BERGHUIS B, VAN DONGEN JW, BREUNING MH, SNIJDERS PJ, RUTTEN WP, SANDKUIJL LA, OOSTRA BA, VAN DUIJN CM, HEUTINK P (2001) A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat Genet 28: 213-214
63. OATES PS, JEFFREY GP, BASCLAIN KA, THOMAS C, MORGAN EH (2000) Iron excretion in iron-overloaded rats following the change from an iron-loaded to an iron-deficient diet. J Gastroenterol Hepatol 15: 665-674
64. OLIVI L, SISK J, BRESSLER J (2001) Involvement of DMT1 in uptake of Cd in MDCK cells: Role of protein kinase C. Am J Physiol Cell Physiol 281: C793-800
65. PAPANIKOLAOU G, SAMUELS ME, LUDWIG EH, MACDONALD ML, FRANCHINI PL, DUBE MP, ANDRES L, MACFARLANE J, SAKELLAROPOULOS N, POLITOU M, NEMETH E, THOMPSON J, RISLER JK, ZABOROWSKA C, BABAKAIFF R, RADOMSKI CC, PAPE TD, DAVIDAS O, CHRISTAKIS J, BRISSOT P, LOCKITCH G, GANZ T, HAYDEN MR, GOLDBERG YP (2004) Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet 36: 77-82
66. PARK CH, VALORE EV, WARING AJ, GANZ T (2001) Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 276: 7806-7810
67. PARKKILA S, WAHEED A, BRITTON RS, FEDER JN, TSUCHIHASHI Z, SCHATZMAN RC, BACON BR, SLY WS (1997) Immunohistochemistry of HLA-H, the protein defective in patients with hereditary hemochromatosis, reveals unique pattern of expression in gastrointestinal tract. Proc Natl Acad Sci USA 94: 2534-2539
68. PARKKILA S, WAHEED A, BRITTON RS, BACON BR, ZHOU XY, TOMATZU S, FLEMING RE, SLY WS (1997) Association of the transferrin receptor in human placenta with HFE, the protein defective in hereditary hemochromatosis. Proc Natl Acad Sci USA 94: 13198-13202
69. PIGEON C, ILYIN G, COURSELAUD B, LEROYER P, TURLIN B, BRISSOT P, LOREAL O (2001) A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 276: 7811-7819
70. ROETTO A, PAPANIKOLAOU G, POLITOU M, ALBERTI F, GIRELLI D, CHRISTAKIS J, LOUKOPOULOS D, CAMASCHELLA C (2003) Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet 33: 21-22
71. ROUAULT T, KLAUSNER R (1997) Regulation of iron metabolism in eukaryotes. Curr Top Cell Regul 35: 1-19
72. ROY CN, PENNY DM, FEDER JN, ENNS CA (1999) The hereditary hemochromatosis protein, HFE, specifically regulates transferrin-mediated iron uptake in HeLa cells. J Biol Chem 274: 9022-9028
73. SU MA, TRENOR CC, FLEMING JC, FLEMING MD, AND ANDREWS MC (1998) The G185R mutation isrupts function of iron transporter Nramp2. Blood 92: 2157-2163
74. TALLKVIST J, BOWLUS CL, LONNERDAL B (2001) DMT1 gene expression and cadmium absorption in human absorptive enterocytes. Toxicol Lett 122: 171-177
75. VULPE CD, KUO YM, MURPHY TL, COWLEY L, ASKWITH C, LIBINA N, GITSCHIER J, ANDERSON GJ (1999) Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat Genet 21: 195-199
76. WAHEED A, PARKKILA S, ZHOU XY, TOMATSU S, TSUCHIHASHI Z, FEDER JN, SCHATZMAN RC, BRITTON RS, BACON BR, SLY WS (1997) Hereditary hemochromatosis: Effects of C282Y and H63D mutations on association with beta2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells. Proc Natl Acad Sci USA 94: 12384-12389
77. WEINSTEIN DA, ROY CN, FLEMING MD, LODA MF, WOLFSDORF JI, ANDREWS NC (2002) Inappropriate expression of hepcidin is associated with iron refractory anemia: Implications for the anemia of chronic disease. Blood 100: 3776-3781
78. WOJCIK JP, SPEECHLEY MR, KERTESZ AE, CHAKRABARTI S, ADAMS PC (2002) Natural history of C282Y homozygotes for hemochromatosis. Can J Gastroenterol 16: 297-302
79. WOLF G, WESSLING-RESNICK M (1994) An integrin-mobilferrin Iron transport pathway in intestine and hematopoietic cells. Nutr Rev 52: 387-389
80. YEH KY, YEH M, GLASS J (2004) Hepcidin regulation of ferroportin 1 expression in the liver and intestine of the rat. Am J Physiol Gastrointest Liver Physiol 286: G385-394
81. ZOLLER H, THEURL I, KOCH RO, MCKIE AT, VOGEL W, WEISS G (2003) Duodenal cytochrome b and hephaestin expression in patients with iron deficiency and hemochromatosis. Gastroenterology 125: 746-754
82. ZHOU XY, TOMATSU S, FLEMING RE, PARKKILA S, WAHEED A, JIANG J, FEI Y, BRUNT EM, RUDDY DA, PRASS CE, SCHATZMAN RC, ONEILL R, BRITTON RS, BACON BR, SLY WS (1998) HFE gene knockout produces mouse model of hereditary hemochromatosis. Proc Natl Acad Sci USA 95: 2492-2497
83. ZÚÑIGA F, OLIVARES E, ASENJO JA, ANDREWS BA (2004) A metabolic model for the optimization of adenoviral vector production. 9th International Conference on Cell Culture Engineering, Cancun, Mexico